Literature DB >> 15645208

Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up.

M S Christiansen1, E Hommel, E Magid, B Feldt-Rasmussen.   

Abstract

AIMS/HYPOTHESIS: To study whether urinary orosomucoid excretion rate (UOER) predicts mortality in normoalbuminuric patients with diabetes at 5 years of follow-up, and to investigate the relationship between orosomucoid in serum and urine.
METHODS: A cohort of 578 patients with diabetes (430 type 2, 148 type 1) was followed prospectively for an average of 5 years. UOER was measured in timed overnight urine samples.
RESULTS: Eighty-two patients with type 2 diabetes and 17 patients with type 1 diabetes died. Among patients with type 2 diabetes, 251 (58%) had normoalbuminuria; increased UOER independently predicted cardiovascular mortality (OR 4.94, 95% CI 1.60-15.22; p<0.006) in those with normoalbuminuria and in the entire cohort of patients with type 2 diabetes (odds ratio 3.63, 95% CI 1.50-8.81; p<0.005). Patients with increased UOER had a higher all-cause mortality than those with normal UOER (log-rank test, p<0.001 for type 2 patients; p<0.04 for type 1 patients). In patients with type 1 diabetes, there were five cardiovascular deaths and no significant predictive value of UOER. Patients with increased UOER had a subclinical increase in serum orosomucoid. CONCLUSION/
INTERPRETATION: Increased UOER was an independent, powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes and in the entire cohort of patients with type 2 diabetes. There were indications of UOER as being a valuable marker in type 1 diabetes that showed differences in survival between patients with normal versus increased UOER. Serum orosomucoid was associated with UOER; UOER may be a marker of low-grade inflammation in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645208     DOI: 10.1007/s00125-004-1630-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Microalbuminuria and mortality in long-duration type 1 diabetes.

Authors:  Kate V Allen; James D Walker
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

2.  Serum and urinary alpha-1 acid glycoprotein in chronic renal failure.

Authors:  M P Vasson; J C Baguet; M R Arveiller; P J Bargnoux; J P Giroud; D Raichvarg
Journal:  Nephron       Date:  1993       Impact factor: 2.847

3.  Population-based survey and analysis of trends in the prevalence of diabetic nephropathy in Type 1 diabetes.

Authors:  J N Harvey; K Rizvi; L Craney; J Messenger; R Shah; P A Meadows
Journal:  Diabet Med       Date:  2001-12       Impact factor: 4.359

4.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

5.  Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

Authors:  C G Schalkwijk; D C Poland; W van Dijk; A Kok; J J Emeis; A M Dräger; A Doni; V W van Hinsbergh; C D Stehouwer
Journal:  Diabetologia       Date:  1999-03       Impact factor: 10.122

6.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

7.  Increased levels of acute-phase serum proteins in diabetes.

Authors:  D E McMillan
Journal:  Metabolism       Date:  1989-11       Impact factor: 8.694

8.  A particle-enhanced turbidimetric immunoassay for quantitative determination of orosomucoid in urine: development, validation and reference values.

Authors:  Merete S Christiansen; Søren Blirup-Jensen; Lise Foged; Marianne Larsen; Erik Magid
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

9.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

Authors:  S P Laing; A J Swerdlow; S D Slater; A C Burden; A Morris; N R Waugh; W Gatling; P J Bingley; C C Patterson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

10.  A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM.

Authors:  A Neil; M Hawkins; M Potok; M Thorogood; D Cohen; J Mann
Journal:  Diabetes Care       Date:  1993-07       Impact factor: 19.112

View more
  11 in total

Review 1.  Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.

Authors:  Sahdeo Prasad; Amit K Tyagi; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-24

2.  Proteomic analysis of human serum from diabetic retinopathy.

Authors:  Yin-Ping Liu; Shui-Wang Hu; Zhen-Feng Wu; Li-Xin Mei; Ping Lang; Xiao-He Lu
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

Review 3.  Proteomics and diabetic nephropathy.

Authors:  Michael L Merchant; Jon B Klein
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

4.  Orosomucoid is an independent predictor of prognosis in chronic heart failure.

Authors:  Petra Kaplan; Bojan Vrtovec; Borut Jug
Journal:  Wien Klin Wochenschr       Date:  2016-07-05       Impact factor: 1.704

5.  The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.

Authors:  Fei Li; Zhe Yu; Pengliang Chen; Guangzheng Lin; Tieqiu Li; Lina Hou; Yuejun Du; Wanlong Tan
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

6.  A point-of-care assay for alpha-1-acid glycoprotein as a diagnostic tool for rapid, mobile-based determination of inflammation.

Authors:  Bryan M Gannon; Marshall J Glesby; Julia L Finkelstein; Tony Raj; David Erickson; Saurabh Mehta
Journal:  Curr Res Biotechnol       Date:  2019-10-25

7.  Urinary orosomucoid: validation of an automated immune turbidimetric test and its possible clinical use.

Authors:  Péter Kustán; Balázs Szirmay; Zoltán Horváth-Szalai; Andrea Ludány; Ágnes Lakatos; Diána Mühl; Per Hjort Christensen; Attila Miseta; Gábor L Kovács; Tamás Kőszegi
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

Review 8.  Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.

Authors:  Hannah Youngblood; Rebekah Robinson; Ashok Sharma; Shruti Sharma
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

9.  Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure.

Authors:  Li-na Hou; Fei Li; Qing-chun Zeng; Liang Su; Ping-an Chen; Zhi-hao Xu; Din-ji Zhu; Chang-hua Liu; Ding-li Xu
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

10.  New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease.

Authors:  Qinjie Weng; Qiongxiu Zhou; Jun Tong; Yuanmeng Jin; Yunzi Liu; Xialian Yu; Xiaoxia Pan; Hong Ren; Weiming Wang; Jingyuan Xie; Nan Chen
Journal:  Clin Proteomics       Date:  2020-05-29       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.